Cerebral Nitinol Stenting in Progressive Stroke and in Crescendo TIAs

Abstract

Background Acute ischemic stroke (AIS) is the third leading cause of death. Arterial stenosis is a common cause of stroke, with a high risk of recurrent stroke. Treatment guidelines for AIS and transient ischemic attack (TIA) are still under debate. Treatment guidelines for progressive stroke or crescendo TIAs do not exist. Percutaneous transluminal angioplasty and stenting (PTAS) is an increasingly attractive treatment option, whose efficacy is yet to be proven. However, stent placement poses both short- and long-term risks such as immediate ischemic events, in-stent stenosis, and stent breakage. Thus the choice of stent type is critical. We report our experience with the LEO + (Balt Extrusion, Montmorency, France) nitinol flexible self-expanding stent for the treatment of progressive cerebrovascular accident or crescendo TIAs.

Methods Twelve patients, presenting with a clinical picture of a crescendo TIA or progressive stroke in evolution not halted by optimal medical care, were treated. Patients had a corresponding major cerebral arterial narrowing and evidence of cerebral infarction on imaging. Patients were followed clinically and radiographically.

Results Twelve patients 17 to 80 years of age were treated during the study period (20 months). Sixteen nitinol flexible self-expandable stents (LEO +) were placed. All patients showed moderate to substantial improvement in neurologic functions after the procedure.

Conclusion PTAS should be considered a treatment option in case of progressive stroke or crescendo TIAs coupled with appropriate anatomical findings. This may allow for a substantial improvement in functional and neurologic status.

Keywords

nitinol stenting - acute ischemic stroke - transient ischemic attack

• References

• 1 Stroke—1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 1989; 20 (10) 1407-1431
• 2 Ansari S, McConnell DJ, Velat GJ , et al. Intracranial stents for treatment of acute ischemic stroke: evolution and current status. World Neurosurg 2011; 76 (6, Suppl): S24-S34
• 3 Chiam PT, Samuelson RM, Mocco J , et al. Navigability trumps all: stenting of acute middle cerebral artery occlusions with a new self-expandable stent. AJNR Am J Neuroradiol 2008; 29 (10) 1956-1958
• 4 Chimowitz MI, Lynn MJ, Howlett-Smith H , et al; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352 (13) 1305-1316
• 5 Wong KS, Li H. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 2003; 34 (10) 2361-2366
• 6 Samaniego EA, Dabus G, Linfante I. Stenting in the treatment of acute ischemic stroke: literature review. Front Neurol 2011; 2: 76
• 7 Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007; 6 (12) 1063-1072
• 8 Kasner SE, Chimowitz MI, Lynn MJ , et al; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113 (4) 555-563
• 9 Nogueira RG, Schwamm LH, Hirsch JA. Endovascular approaches to acute stroke, part 1: Drugs, devices, and data. AJNR Am J Neuroradiol 2009; 30 (4) 649-661
• 10 Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333 (24) 1581-1587
• 11 Nogueira RG, Liebeskind DS, Sung G, Duckwiler G, Smith WS ; MERCI; Multi MERCI Writing Committee. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. . Stroke 2009; 40 (12) 3777-3783
• 12 Gobin YP, Starkman S, Duckwiler GR , et al. MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004; 35 (12) 2848-2854
• 13 Smith WS, Sung G, Saver J , et al; Multi MERCI Investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39 (4) 1205-1212
• 14 Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40 (8) 2761-2768
• 15 Chimowitz MI, Lynn MJ, Derdeyn CP , et al; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011; 365 (11) 993-1003
• 16 Levy EI, Chaturvedi S. Perforator stroke following intracranial stenting: a sacrifice for the greater good?. Neurology 2006; 66 (12) 1803-1804
• 17 Levy EI, Ecker RD, Hanel RA , et al. Acute M2 bifurcation stenting for cerebral infarction: lessons learned from the heart: technical case report. Neurosurgery 2006; 58 (3) E588 ; discussion E588
• 18 Levy EI, Mehta R, Gupta R , et al. Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 2007; 28 (5) 816-822
• 19 Samaniego EA, Hetzel S, Thirunarayanan S, Aagaard-Kienitz B, Turk AS, Levine R. Outcome of symptomatic intracranial atherosclerotic disease. Stroke 2009; 40 (9) 2983-2987
• 20 Linfante I, Samaniego EA, Geisbüsch P, Dabus G. Self-expandable stents in the treatment of acute ischemic stroke refractory to current thrombectomy devices. Stroke 2011; 42 (9) 2636-2638
• 21 Levy EI, Turk AS, Albuquerque FC , et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007; 61 (3) 644-650 ; discussion 650–651
• 22 Stoeckel D, Pelton A, Duerig T. Self-expanding nitinol stents: material and design considerations. Eur Radiol 2004; 14 (2) 292-301
• 23 Hacke W, Kaste M, Bluhmki E , et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359 (13) 1317-1329
• 24 Derdeyn CP, Chimowitz MI, Lynn MJ , et al; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet 2014; 383 (9914) 333-341
• 25 Lutsep HL, Barnwell SL, Larsen DT , et al; SAMMPRIS Investigators. Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke 2015; 46 (3) 775-779
• 26 Abou-Chebl A, Steinmetz H. Critique of “Stenting versus aggressive medical therapy for intracranial arterial stenosis” by Chimowitz et al in the New England Journal of Medicine. Stroke 2012; 43 (2) 616-620
• 27 Ay H, Arsava EM, Johnston SC , et al. Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke 2009; 40 (1) 181-186
• 28 Cragg A, Lund G, Rysavy J, Castaneda F, Castaneda-Zuniga W, Amplatz K. Nonsurgical placement of arterial endoprostheses: a new technique using nitinol wire. Radiology 1983; 147 (1) 261-263
• 29 Dotter CT, Buschmann RW, McKinney MK, Rösch J. Transluminal expandable nitinol coil stent grafting: preliminary report. Radiology 1983; 147 (1) 259-260
• 30 Valdivia y Alvarado M, Ebrahimi N, Benndorf G. Study of conformability of the new LEO plus stent to a curved vascular model using flat-panel detector computed tomography (DynaCT). Neurosurgery 2009; 64 (3, Suppl): ons130-ons134 ; discussion ons134
• 31 Berkhemer OA, Fransen PS, Beumer D , et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372 (1) 11-20
• 32 Cohen-Inbar O, Amsalem Y, Soustiel JF. Nitinol stenting in post-traumatic pseudo-aneurysm of internal carotid artery. Open J Mod Neurosurg 2012; 2: 45-49